2024-09-02 - Analysis Report
##  UNH Stock Analysis

**Company Overview:** UnitedHealth Group Incorporated (UNH) is a leading provider of health care products and services in the United States.

**1. Performance & Relative Performance:**

* UNH has a cumulative return of **104.69%** compared to **89.66%** for the S&P 500 (VOO).
* This represents an outperformance of **15.03%**.
* The current relative outperformance is at **43.78%**, indicating it is currently outperforming S&P 500 within the historical range.

**2. Recent Price Movement:**

* Closing Price: **590.2**
* 5-Day Moving Average: **588.96**
* 20-Day Moving Average: **577.57**
* 60-Day Moving Average: **538.91**

**3. Technical Indicators:**

* **RSI:** **83.85** - This indicates that UNH is in overbought territory.
* **PPO:** **-0.12** - This suggests a potential for price correction in the short term.
* **Delta_Previous_Relative_Divergence:** **-10.56** - Indicates a short-term downward trend in relative outperformance.
* **Expected Return:** **38.82%** - This is the projected 5-year expected return based on current investment.

**4. Recent Earnings & Outlook:**

| Date  | EPS | Revenue |
|---|---|---|
| 2024-08-09 | 4.58 | 98.86 B$ |
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2023-08-02 | 5.89 | 92.90 B$ |
| 2024-08-09 | 5.89 | 92.90 B$ |

The most recent earnings report for Q2 2024 showed an EPS of **4.58**, surpassing analyst estimates of **4.47**.  This suggests a positive outlook for the company.

**5. Overall Analysis:**

* UNH has consistently outperformed the S&P 500, with a current outperformance of **15.03%**.
* Technical indicators suggest the stock might be overbought and prone to short-term correction.
* Despite the overbought conditions, the recent earnings report indicates a positive outlook for the company.

**6. Conclusion:**

UNH's strong performance and positive earnings outlook make it an attractive investment. However, its high RSI and potential for short-term correction should be considered. Investors should monitor the stock closely and consider its potential overbought condition. 
